| Identify elements of the current regulatory framework for compounding in Canada as it applies to Federal, Provincial/Territorial jurisdictional law, and standards of practice. |  |  |  |  |  | 
 | Describe quality assurance, risk management, and verification program requirements outlined in the Guidance Document for Pharmacy Compounding of Non-sterile Preparations. |  |  |  |  |  | 
 | Identify policy and procedure requirements that reflect the current NAPRA model standards. |  |  |  |  |  | 
 | Detail current requirements of master formulation and compounding records. |  |  |  |  |  | 
 | Discuss approaches to ensure personnel safety, and the quality and safety of non-sterile preparations. |  |  |  |  |  | 
 | Apply and adapt standards of practice to best suit your compounding practice. |  |  |  |  |  | 
 | Demonstrate the application and integration of a learned policy and procedure infrastructure into your practice. |  |  |  |  |  | 
 | Differentiate competency assessments from compliance indicators. |  |  |  |  |  | 
 | Integrate a best practice’s approach commensurate with the size, complexity, and risks associated specifically to your compounding practice. |  |  |  |  |  | 
 | Develop a strategic action plan to manage the implementation of the new 2018 NAPRA standards of practice. |  |  |  |  |  |